Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HIV-1 testing: product development strategies.

T D Gottfried1, H B Urnovitz

  • 1Calypte Biomedical Corporation, Berkeley, CA 94710.

Trends in Biotechnology
|February 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AIDS epidemic at the beginning of the third millennium: time for a new AIDS vaccine strategy.

Vaccine·2001
Same author

RT-PCR amplicons in the plasma of multiple myeloma patients--clinical relevance and molecular pathology.

Acta oncologica (Stockholm, Sweden)·2001
Same author

Beyond danger: unmethylated CpG dinucleotides and the immunopathogenesis of disease.

Immunology letters·2000
Same author

Antibody to human endogenous retrovirus peptide in urine of human immunodeficiency virus type 1-positive patients.

Clinical and diagnostic laboratory immunology·1999
Same author

Urine antibody tests: new insights into the dynamics of HIV-1 infection.

Clinical chemistry·1999
Same author

Re: Cell and molecular biology of simian virus 40: implications for human infections and disease.

Journal of the National Cancer Institute·1999
Same journal

A caspase-3-activated protein expression system for apoptosis visualization and apoptosis-pyroptosis conversion to boost antitumor activity.

Trends in biotechnology·2026
Same journal

Over 4 months of ethylene production using solid-state photosynthetic cell factories.

Trends in biotechnology·2026
Same journal

Closing the nitrogen loop in groundwater with biohybrid technologies.

Trends in biotechnology·2026
Same journal

Engineering environmental bacteria for whole-cell PET hydrolysis and assimilation.

Trends in biotechnology·2026
Same journal

Acoustic cavitation-enhanced lymphatic trafficking of inhaled bacterial-sourced biohybrid vaccines for antitumor immunity.

Trends in biotechnology·2026
Same journal

Make uphill thermodynamics downhill in pathway design.

Trends in biotechnology·2026
See all related articles

Diagnostic product development for acquired immune deficiency syndrome (AIDS) evolved from blood supply screening to personal health monitoring. Advances in understanding human immunodeficiency virus (HIV) drive new tests for disease staging and prognosis.

Area of Science:

  • Immunology
  • Virology
  • Medical Diagnostics

Background:

  • Acquired immune deficiency syndrome (AIDS) pathogenesis is closely tied to human immunodeficiency virus (HIV) knowledge.
  • Diagnostic product development for AIDS has progressed significantly since 1984.
  • Initial efforts focused on ensuring blood supply safety.

Purpose of the Study:

  • To review the evolution of diagnostic product development strategies for HIV/AIDS.
  • To highlight the shift in focus from blood screening to patient-centered diagnostics.
  • To outline the current trends in developing tests for disease monitoring and prognosis.

Main Methods:

  • Literature review of HIV/AIDS diagnostic product development from 1984 to present.
  • Analysis of market trends and technological advancements.

Related Experiment Videos

  • Examination of the link between pathogenesis understanding and diagnostic capabilities.
  • Main Results:

    • Early HIV-1 antibody screening tests were crucial for blood safety.
    • Success in screening led to development for personal healthcare and applicant testing.
    • Current development focuses on markers for disease progression and therapeutic monitoring.

    Conclusions:

    • Diagnostic strategies for HIV/AIDS are directly influenced by scientific understanding of the virus and disease.
    • The field has transitioned from public health screening to personalized patient management.
    • Future diagnostic development aims to support disease staging, monitoring, and prognosis for improved patient outcomes.